Health
Experimental intranasal influenza vaccine produces durable immune response – News-Medical.Net
An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study published in the Journal…
An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study published in the Journal of Clinical Investigation. The investigational vaccine, called Ad4-H5-VTN, is a recombinant, replicating adenovirus vaccine designed to spur antibodies to hemagglutinin, a protein found on the surface of influenza viruses that attaches to human cells.
The investigational vaccine was developed by Emergent Biosolutions Inc., (Gaithersburg,…
-
General10 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
General23 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News18 hours agoPrime Minister Anthony Albanese calls for political temperature to be ‘turned down’ after alleged death threat
-
Noosa News12 hours agoPerth Royal Show attendance slumps to 10-year low